ArticleCureus2025
Autoimmune Gastritis Complicated by Primary Biliary Cholangitis: A Report of Two Cases and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Immunological and clinical overlap between autoimmune gastritis and autoimmune liver diseases: a prospective cohort study.Frontiers in immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although autoimmune gastritis (AIG) is often associated with various autoimmune diseases, including type 1 diabetes and Hashimoto's thyroiditis, it is rarely associated with primary biliary cholangitis (PBC). Herein, we present two cases in which AIG was found to be a complication during follow-up of PBC, both histologically diagnosed as AIG with positive autoantibodies and also serologically typical for AIG, including pepsinogen and gastrin. In the first case, a 60-year-old woman with PBC was suspected of having AIG based on endoscopic findings. A definitive diagnosis of AIG was established based on a positive anti-parietal cell antibody test and characteristic histologic findings. The patient exhibited a low pepsinogen I level (5.5 pg/mL; normal: >70 pg/mL) and hypergastrinemia (637 pg/mL; normal: 37-172 pg/mL). Additionally, she was diagnosed with Hashimoto's thyroiditis, confirmed by the presence of anti-thyroid antibodies and an enlarged thyroid gland. In the second case, a 70-year-old woman with PBC was suspected of having AIG due to the low pepsinogen I level (5.8 pg/mL). The definitive diagnosis was established based on the presence of positive anti-intrinsic factor antibodies and characteristic histologic findings. The patient also exhibited hypergastrinemia (2845 pg/mL), but no additional autoimmune diseases were observed. In reviewing past case reports, we identified seven previous reports of AIG with PBC other than our two cases. Approximately half (4/9) were macrocytic anemia, and approximately half (4/9) were positive for anti-thyroid antibodies, which is higher than that expected for conventional PBC. Because AIG should not be misdiagnosed because of the high frequency of associated malignancies, other concomitant autoimmune diseases, and vitamin B12 deficiency, it should be considered in the surveillance of PBC, especially in those with macrocytic anemia or positive antithyroid antibodies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.